Genes may hold key to better heart shock treatment
NCT ID NCT05728359
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how genes affect the immune system and treatment responses in people with cardiogenic shock, a life-threatening condition where the heart suddenly can't pump enough blood. Researchers will collect blood samples from 300 patients to identify genetic patterns linked to survival. The goal is to better understand why outcomes vary and pave the way for more personalized care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOGENIC SHOCK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Barts Health NHS trust
RECRUITINGLondon, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a temporary heart pump save more lives in cardiogenic shock?
- Could starting dialysis sooner save more hearts?
- A tiny probe into the heart's hidden reserve could forecast who needs a transplant
- Can a tiny heart pump Fine-Tune support for failing hearts?
- Could a key hormone be missing in septic shock?
- Could a simple filter tame the deadly inflammation of heart shock?